Evidence map›Paper›PMID 33103553›Full record

ArticleCell cycle (Georgetown, Tex.)2020

The adenoviral protein E4orf4: a probing tool to decipher mechanical stress-induced nuclear envelope remodeling in tumor cells.

Kévin Jacquet, Marc-Antoine Rodrigue, Darren E Richard, Josée N Lavoie

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kévin JacquetCentre de Recherche sur le Cancer de l'Université Laval , Québec, Canada.
Marc-Antoine RodrigueCentre de Recherche sur le Cancer de l'Université Laval , Québec, Canada.
Darren E RichardCentre de Recherche sur le Cancer de l'Université Laval , Québec, Canada.ORCID 0000-0003-2690-0480
Josée N LavoieCentre de Recherche sur le Cancer de l'Université Laval , Québec, Canada.ORCID 0000-0001-6912-1132
Centre hospitalier de l'Université Laval · CAUniversité Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human adenovirus (Ad) type 2/5 early region 4 (E4) ORF4 protein (E4orf4) exerts a remarkable tumor cell-selective killing activity in mammalian cells. This indicates that E4orf4 can target tumor cell-defining features and is a unique tool to probe cancer cell vulnerabilities. Recently, we found that E4orf4, through an interaction with the polarity protein PAR3, subverts nuclear envelope (NE) remodeling processes in a tumor cell-selective manner. In this Perspective, we outline mechanical signals that modify nuclear dynamics and tumor cell behavior to highlight potential mechanisms for E4orf4's tumoricidal activity. Through an analysis of E4orf4's cellular targets, we define a protein subnetwork that comprises phosphatase systems interconnected to polarity protein hubs, which could contribute to enhanced NE plasticity. We infer that elucidating E4orf4's protein network at a functional level could uncover key mechanisms of NE remodeling that define the tumor cell phenotype.

Indexed as

Stress, MechanicalAdaptor Proteins, Signal TransducingAnimalsApoptosisCarcinogenesisCell Cycle ProteinsCell NucleusDrosophilaHippo Signaling PathwayHumansNeoplasmsNuclear EnvelopePhenotypeProtein Interaction MapsProtein Phosphatase 2Viral ProteinsAdaptor Proteins, Signal TransducingCell Cycle ProteinsE4orf4 protein, adenovirusProtein Phosphatase 2Viral Proteinsactincancer vulnerabilitycellular contractilityNuclear envelopenuclear rupture and repairpolarity proteins

Identifiers

PMID33103553
PMCPMC7714506
OpenAlexW3094317173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.